Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients wi...
Leadership
Harout Semerjian
CEO, President & Director
Michelle J. Robertson
EVP, CFO, Treasurer and Principal Financial & Accounting Officer
Joseph Emile Eid M.D.
Executive VP of Research & Development and Chief Medical Officer
Ahmed ElNawawi
Executive VP & Chief Commercial Officer
Shanthakumar Tyavanagimatt
Senior VP & Chief Technical Officer
Dawn Schottlandt CFA
Senior Vice President of Investor Relations & Corporate Affairs
